Biblio
Export 1152 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is A [Clear All Filters]
“Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 241-260, 2023.
, “Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 241-260, 2023.
, “Early Amnestic Mild Cognitive Impairment Is Associated with Reduced Total Cerebral Blood Flow with no Brain Tissue Loss.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1313-1322, 2023.
, “Early Depressive Symptoms Predict Faster Dementia Progression in Autosomal-Dominant Alzheimer's Disease.”, J Alzheimers Dis, 2023.
, “Early Depressive Symptoms Predict Faster Dementia Progression in Autosomal-Dominant Alzheimer's Disease.”, J Alzheimers Dis, 2023.
, “Post-Translational Chemical Modifications of Amyloid-β Peptides by 4-Hydroxy-2-Nonenal.”, J Alzheimers Dis, 2023.
, “Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1103-1114, 2022.
, “Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1103-1114, 2022.
, “Alzheimer's Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 88, no. 3, pp. 903-931, 2022.
, “Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1537-1547, 2022.
, “Association of Brain Volume and Retinal Thickness in the Early Stages of Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 2, pp. 743-752, 2022.
, “Associations Between Vascular Risk Factor and Perivascular Spaces in Adults with Intact Cognition, Mild Cognitive Impairment, and Dementia.”, J Alzheimers Dis, vol. 89, no. 2, pp. 437-448, 2022.
, “Associations Between Vascular Risk Factor and Perivascular Spaces in Adults with Intact Cognition, Mild Cognitive Impairment, and Dementia.”, J Alzheimers Dis, vol. 89, no. 2, pp. 437-448, 2022.
, “Augmenting Imaging Biomarker Performance with Blood-Based Gene Expression Levels for Predicting Alzheimer's Disease Progression.”, J Alzheimers Dis, vol. 87, no. 2, pp. 583-594, 2022.
, “Automated Early Detection of Alzheimer's Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1075-1089, 2022.
, “Bifidobacterium breve MCC1274 Supplementation Increased the Plasma Levels of Metabolites with Potential Anti-Oxidative Activity in APP Knock-In Mice.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1413-1425, 2022.
, “A Bioinformatics Approach Toward Unravelling the Synaptic Molecular Crosstalk Between Alzheimer's Disease and Diabetes.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1917-1933, 2022.
, “Blood Pressure and Later-Life Cognition in Hispanic and White Adults (BP-COG): A Pooled Cohort Analysis of ARIC, CARDIA, CHS, FOS, MESA, and NOMAS.”, J Alzheimers Dis, vol. 89, no. 3, pp. 1103-1117, 2022.
, “Brain Tissue-Derived Extracellular Vesicles in Alzheimer's Disease Display Altered Key Protein Levels Including Cell Type-Specific Markers.”, J Alzheimers Dis, vol. 90, no. 3, pp. 1057-1072, 2022.
, “Caregiver Tele-Assistance for Reduction of Emotional Distress During the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience.”, J Alzheimers Dis, vol. 85, no. 3, pp. 1045-1052, 2022.
, “Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation.”, J Alzheimers Dis, vol. 90, no. 2, pp. 667-680, 2022.
, “Circulating Cell-Free Genomic DNA Is Associated with an Increased Risk of Dementia and with Change in Cognitive and Physical Function.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1233-1240, 2022.
, “Clinical and Imaging Determinants of Neurocognitive Disorders in Post-Acute COVID-19 Patients with Cognitive Complaints.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1239-1250, 2022.
, “Clinical and Imaging Determinants of Neurocognitive Disorders in Post-Acute COVID-19 Patients with Cognitive Complaints.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1239-1250, 2022.
, “Clinical and Imaging Determinants of Neurocognitive Disorders in Post-Acute COVID-19 Patients with Cognitive Complaints.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1239-1250, 2022.
,